Thus, the identification of novel factors synergistically exacerbating the c-MYC pathway in hepatocarcinogenesis could provide significant insights into the mechanisms of tumor heterogeneity, thereby improving treatment options in liver cancer. This evidence concerns the gene MYC and liver cancer.